Abiraterone Acetate
Local Recurrence of Malignant Tumor of Rectum
Hospital San Carlos, MadridActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Local Recurrence of Malignant Tumor of Rectum cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LEUPROLIDE Hospital San Carlos, Madrid | D | |
Belzutifan Hospital San Carlos, Madrid | D |
Same molecule, other indications
Abiraterone Acetate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →